Invention Grant
- Patent Title: 5-CNAC as oral delivery agent for parathyroid hormone fragments
-
Application No.: US13327114Application Date: 2011-12-15
-
Publication No.: US09272040B2Publication Date: 2016-03-01
- Inventor: Moise Azria , Simon David Bateman
- Applicant: Moise Azria , Simon David Bateman
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Dilworth & Barrese, LLP
- Agent Ann R. Pokalsky
- Main IPC: A61K38/29
- IPC: A61K38/29 ; A61K47/18 ; A61K9/48 ; A61K31/198
Abstract:
Pharmaceutical compositions for the effective oral delivery of a parathyroid hormone, PTH, as well as methods for administration of the compositions are provided. Additionally, methods for stimulating new bone formation and treating and/or preventing osteoporosis are also provided.
Public/Granted literature
- US20120088725A1 5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTS Public/Granted day:2012-04-12
Information query
IPC分类:
